BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11903381)

  • 1. Organ procurement organization (OPO), best practices.
    Bollinger RR; Heinrichs DR; Seem DL; Rosendale JD; Johnson KS;
    Clin Transplant; 2001; 15 Suppl 6():16-21. PubMed ID: 11903381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of National Organ Donation Rates and Organ Procurement Organization Metrics.
    DeRoos LJ; Zhou Y; Marrero WJ; Tapper EB; Sonnenday CJ; Lavieri MS; Hutton DW; Parikh ND
    JAMA Surg; 2021 Feb; 156(2):173-180. PubMed ID: 33263743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three-tier system for evaluation of organ procurement organizations' willingness to pursue and utilize nonideal donor lungs.
    Halpern SE; McConnell A; Peskoe SB; Raman V; Jawitz OK; Choi AY; Neely ML; Palmer SM; Hartwig MG
    Am J Transplant; 2021 Mar; 21(3):1269-1277. PubMed ID: 33048423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of geographic variability in mortality and eligible deaths between organ procurement organizations.
    Cannon RM; Jones CM; Davis EG; Franklin GA; Gupta M; Shah MB
    Am J Transplant; 2019 Oct; 19(10):2756-2763. PubMed ID: 30980456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of pediatric deceased donor consent: A survey of organ procurement organizations.
    Chapman GB; Butler A; Lanyon M; Godown J; Lebovitz DJ
    Pediatr Transplant; 2023 Jun; 27(4):e14514. PubMed ID: 36945079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ Procurement Organization and transplant center effects on cadaver renal transplant outcomes.
    Cho YW; Cecka JM
    Clin Transpl; 1996; ():427-41. PubMed ID: 9286586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of donor consent mechanism on organ procurement organization performance in the United States.
    Valikodath N; Lambert AN; Butler A; Lebovitz DJ; Chapman G; Xu M; Slaughter JC; Menachem JN; Godown J
    J Heart Lung Transplant; 2023 May; 42(5):627-636. PubMed ID: 36868968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consent for donation after cardiac death: a survey of organ procurement organizations.
    Kalkbrenner KJ; Hardart GE
    J Intensive Care Med; 2012; 27(4):253-63. PubMed ID: 21576191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Organ Procurement Organization Social Network Centrality and Kidney Discard and Transplant Outcomes.
    Butala NM; King MD; Reitsma W; Formica RN; Abt PL; Reese PP; Parikh CR
    Transplantation; 2015 Dec; 99(12):2617-24. PubMed ID: 26102610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When the living and the deceased cannot agree on organ donation: a survey of US organ procurement organizations (OPOs).
    Chon WJ; Josephson MA; Gordon EJ; Becker YT; Witkowski P; Arwindekar DJ; Naik A; Thistlethwaite JR; Liao C; Ross LF
    Am J Transplant; 2014 Jan; 14(1):172-7. PubMed ID: 24369025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The consent process for cadaveric organ procurement: how does it work? How can it be improved?
    Wendler D; Dickert N
    JAMA; 2001 Jan; 285(3):329-33. PubMed ID: 11176844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in Organ Procurement Organization Performance by Individual Hospital in the United States.
    Johnson W; Kraft K; Chotai P; Lynch R; Dittus RS; Goldberg D; Ye F; Doby B; Schaubel DE; Shah MB; Karp SJ
    JAMA Surg; 2023 Apr; 158(4):404-409. PubMed ID: 36753195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U.S. system for organ procurement and transplantation.
    Schaeffer MJ; Alexander DC
    Am J Hosp Pharm; 1992 Jul; 49(7):1733-40. PubMed ID: 1621733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid improvement in organ procurement organization performance: Potential for change and impact of new leadership.
    Niroomand E; Mantero A; Narasimman M; Delgado C; Goldberg D
    Am J Transplant; 2020 Dec; 20(12):3567-3573. PubMed ID: 32476235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procurement characteristics of high- and low-performing OPOs as seen in OPTN/SRTR data.
    Lynch RJ; Doby BL; Goldberg DS; Lee KJ; Cimeno A; Karp SJ
    Am J Transplant; 2022 Feb; 22(2):455-463. PubMed ID: 34510735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using a standardized donor ratio to assess the performance of organ procurement organizations.
    Stogis S; Hirth RA; Strawderman RL; Banaszak-Holl J; Smith DG
    Health Serv Res; 2002 Oct; 37(5):1329-44. PubMed ID: 12479499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Donor Service Area Market Competition Associated With Organ Procurement Organization Performance?
    Adler JT; Yeh H; Markmann JF; Axelrod DA
    Transplantation; 2016 Jun; 100(6):1349-55. PubMed ID: 26516674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost Structures of US Organ Procurement Organizations.
    Held PJ; Bragg-Gresham JL; Peters TG; McCormick F; Chertow G; Vaughan WP; Roberts JP
    Transplantation; 2021 Dec; 105(12):2612-2619. PubMed ID: 33988344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Step toward Standardization: Results of two National Surveys of Best Practices in Donation after Circulatory Death Liver Recovery and Recommendations from The American Society of Transplant Surgeons and Association of Organ Procurement Organizations.
    Hobeika MJ; Glazner R; Foley DP; Hanish S; Loss G; Quintini C; Eidbo E; Zollinger C; Ruterbories J; Lebovitz DJ; Axelrod D
    Clin Transplant; 2020 Oct; 34(10):e14035. PubMed ID: 32654227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Envisioning and Leading Organizational Transformation: One Organ Procurement Organization's Journey.
    Orlowski JP
    Cureus; 2016 Nov; 8(11):e879. PubMed ID: 28003943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.